mutations and complicated kar yotype. It follows a linear evolution with the CLL clone throughout the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding locations in the genome, are primarily located in Lively promoters or enhancers, and modify the binding web sites of many transcription com